The Native Plant Society is empowering the next generation of ecologists by awarding grants that support essential fieldwork and research. Students will not only advance their studies through activities like DNA sequencing and ecological monitoring but also enrich the community by sharing their findings.

In a surprising turn of events, researchers from Florida Atlantic University have accidentally documented a great white shark in an area where such sightings are rare, thanks to a nurse shark’s camera. This unexpected encounter could provide valuable insights into the behavior and distribution of these elusive predators.

With few effective treatments available for amyotrophic lateral sclerosis, the ashwagandha plant emerges as a beacon of hope for patients battling this debilitating disease. Could this ancient remedy provide relief where modern medicine has struggled?

Researchers have developed nerve grafts that can evade the immune system, dubbed an ‘invisibility cloak.’ These grafts are currently being trialed as a treatment for Parkinson’s disease, potentially revolutionizing therapies for neurodegenerative conditions.

Imagine harnessing the benefits of dreaming without closing your eyes. Scientists now suggest that certain psychedelics could make this a reality.

CERo Therapeutics has expanded its patent portfolio with new approvals in the United States, marking a significant milestone in the company’s growth. This strategic move strengthens its position in the biotechnology industry and underscores its commitment to innovation.

Trilobio introduced its comprehensive robotics lab equipment and software platform at the SLAS conference. Designed by biologists for biologists, the platform enables users to operate robots within 30 minutes of unboxing and design research protocols in minutes.

Rhythm Pharmaceuticals announces promising results from their Phase 3 TRANSCEND trial, where setmelanotide significantly reduced BMI in patients with acquired hypothalamic obesity. This breakthrough offers new hope for treating this rare condition resulting from hypothalamic damage.

Context Therapeutics has reported its fiscal year 2024 results, highlighting significant strides in cancer immunotherapy. With strategic acquisitions and a strengthened financial position, the biotech firm is poised to advance its pipeline of T cell engaging bispecific antibodies targeting solid tumors.

Northwestern University researchers have uncovered how specific structural features in engineered cell receptors influence their function. By utilizing advanced computational tools, they offer new insights that could revolutionize synthetic cell therapies.

Anbio Biotechnology, a global leader in in vitro diagnostics, has successfully closed its $8 million initial public offering, marking its debut on the Nasdaq Global Market under the ticker symbol “NNNN”. The company plans to utilize the funds to expand its global footprint, accelerate research and development, and advance its mission to transform the diagnostics industry.

Ignite Proteomics has completed the acquisition of PLA code 0249U for its advanced breast cancer assay, integrating laboratory capabilities and intellectual property. This milestone enhances the test’s recognition in billing systems, paving the way for wider adoption in precision oncology.

The manufacturing industry is grappling with persistent challenges, notably a growing skills gap. Could implementing AI be the key to expanding human potential and bridging this divide?

Jaguar has received regulatory clearance in Germany and Italy to conduct a study of Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF). This approval marks a significant advancement in rare disease research and offers potential hope for patients.

NAYA Biosciences has announced the nomination of new board members, marking a significant step in its corporate governance. Reported by Investing.com on February 19, 2025, this move highlights the company’s ongoing developments in the pharma and healthcare industry.

Illumina has announced a first-of-its-kind spatial transcriptomics technology, marking a significant advancement in the field. The unveiling positions the company at the forefront of technological innovation.

Moderna has reported a decline in its revenue for the fourth quarter of 2024, according to a recent publication by Yahoo Finance. The report highlights a shift in the company’s financial performance during this period.

As healthcare professionals grapple with an overwhelming influx of data, AI-generated summaries are emerging as crucial tools to streamline workflows and enhance patient care. While promising significant efficiency gains, ensuring the accuracy and trustworthiness of these summaries remains a critical challenge.

From C-3PO to Wall-E, friendly robots have captured our imaginations and our hearts on the big screen. These films showcase robots that prove machines can have heart, offering an optimistic view of technology’s potential.

Hohem has unveiled the iSteady M7, an AI-powered gimbal that turns smartphones into professional filming tools. With advanced subject tracking, a detachable touchscreen controller, and extended battery life, the iSteady M7 offers content creators a versatile and powerful stabilization solution.

From significant corporate expansions to generous community contributions, businesses in Hampton Roads are propelling economic growth and fostering community development. Recent initiatives highlight a strong commitment to innovation, philanthropy, and leadership in the region.